De Novo Ventures, based in northern California, invests in life science companies primarily based in the western United States. Its targeted areas of interest include medical devices, genomics, biotech/pharmaceuticals, drug delivery, and healthcare Internet. De Novo raised $100 million in the spring of 2000, and invests primarily in seed and early-stage companies. De Novo's team brings years of experience in venture capital investing, entrepreneurism, operating and management roles, and an intimate understanding of the practice of medicine.
